Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001346814 | SCV001541045 | uncertain significance | Fanconi anemia | 2021-08-26 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with cysteine at codon 1084 of the FANCA protein (p.Arg1084Cys). The arginine residue is weakly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs764206631, ExAC 0.002%). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478791 | SCV004218553 | uncertain significance | not provided | 2023-07-11 | criteria provided, single submitter | clinical testing | In the published literature, this variant has been reported in individuals with ovarian cancer (PMID: 32546565 (2021)). The variant has also been reported as a somatic variant in pancreatic cancer (PMID: 30836094 (2019), melanoma (PMID: 30050716 (2018)), colorectal cancer (PMID: 32799124 (2020)), and breast cancer (PMID: 32903519 (2020)). The frequency of this variant in the general population, 0.000065 (5/ 113288 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. |
Fulgent Genetics, |
RCV005014463 | SCV005644725 | uncertain significance | Fanconi anemia complementation group A | 2024-06-20 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001346814 | SCV002092544 | uncertain significance | Fanconi anemia | 2020-01-13 | no assertion criteria provided | clinical testing |